Xeris Biopharma Holdings, Inc. - COM (XERS)

Historical Holders from Q3 2021 to Q3 2025

Symbol
XERS on Nasdaq
Type / Class
Equity / COM
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
96,902,244
Holdings value
$788,823,033
% of all portfolios
0%
Number of holders
228
Number of buys
133
Number of sells
-89
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Xeris Biopharma Holdings, Inc. - COM (XERS)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 96,902,244 $788,823,033 +$58,408,431 $8.14 228
2025 Q2 90,495,534 $422,617,978 +$16,622,096 $4.67 200
2025 Q1 86,799,982 $476,523,606 +$123,713,876 $5.49 199
2024 Q4 65,548,446 $222,208,577 +$5,693,687 $3.39 161
2024 Q3 63,918,467 $182,169,401 +$11,712,690 $2.85 143
2024 Q2 60,623,914 $136,403,872 +$57,516 $2.25 132
2024 Q1 60,495,199 $133,691,334 +$1,259,202 $2.21 140
2023 Q4 59,921,867 $140,817,138 +$3,980,290 $2.35 118
2023 Q3 55,319,172 $102,889,496 -$2,383,422 $1.86 109
2023 Q2 55,920,487 $146,506,955 +$17,809,976 $2.62 101
2023 Q1 49,463,144 $80,622,599 -$5,927,964 $1.63 89
2022 Q4 53,916,182 $71,703,555 -$5,395,029 $1.33 93
2022 Q3 57,306,752 $89,403,802 -$3,332,109 $1.56 97
2022 Q2 59,291,260 $91,305,115 +$12,225,836 $1.54 95
2022 Q1 50,404,861 $129,034,768 +$23,839,809 $2.56 97
2021 Q4 40,971,724 $120,062,000 +$117,961,261 $2.93 85
2021 Q3 704,170 $1,725,000 +$1,725,000 $2.45 1